Drug Makers May Be Allowed To Determine Own India Price-Abuse Fines
This article was originally published in PharmAsia News
Executive Summary
Around 30 foreign and domestic drug makers may not face fines as large as they had expected after India's Supreme Court dismissed their challenges to the nation's price-setting policy.